Femasys

NEWS

Pictured: IVF collage/Nicole Bean for BioSpace

Policy

Alabama Ruling, Political Blowback Rattle In Vitro Fertilization Market

A controversial decision by the Alabama Supreme Court temporarily chilled IVF before igniting nationwide pushes to protect access to this type of fertility treatment, leaving drugmakers with questions.

March 12, 2024

5 min read

Neil Versel

IN THE PRESS

Press Releases

Femasys Appoints Dr. Kenneth D. Eichenbaum to Board of Directors

March 18, 2026

5 min read

Press Releases

Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal Trial Enrollment

March 10, 2026

7 min read

Press Releases

Femasys Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 27, 2026

March 2, 2026

4 min read

Press Releases

Femasys Announces FemBloc® Permanent Birth Control Has Achieved MDSAP Certification, Advancing Global Market Access

February 26, 2026

6 min read

Press Releases

Femasys Receives AMA CPT Editorial Panel Approval for New Category III CPT Code for FemaSeed Intratubal Insemination

February 23, 2026

5 min read

Press Releases

Femasys Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products

February 4, 2026

6 min read

Press Releases

Femasys Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement

January 15, 2026

5 min read

Press Releases

Femasys Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed® in Community-Based Care

January 14, 2026

5 min read

Press Releases

Femasys Secures U.S. FDA Clearance for Next-Generation FemVue Diagnostic Device

December 19, 2025

5 min read

Press Releases

PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment

November 26, 2025

2 min read

AWARDS

JOBS